Newsroom

RIYADH, Saudi Arabia--(BUSINESS WIRE)--Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE:TDY), announced that it has appointed Tarik Solomon as managing director for the Middle East and North Africa (MENA). Based in Riyadh, Solomon will oversee the company’s regional growth strategy, partnerships, and localization initiatives across defense, industrial, and emerging technology sectors. He will report to Dr. JihFen Lei, president of Teledyne FLIR Defense. Teledyne Technolog...

WASHINGTON--(BUSINESS WIRE)--Westinghouse Electric Company en MVM Group hebben een contract getekend om de brandstoflevering in Hongarije te diversifiëren. De kerncentrale van Paks (NPP) krijgt hierdoor een betrouwbare levering van Westinghouse VVER-brandstof, die in Europa wordt geproduceerd. De leveringen van Westinghouse VVER-440-brandstof zullen in 2028 van start gaan, afhankelijk van de vergunningsprocedures. “Onze overeenkomst met Westinghouse is een duidelijk antwoord op de huidige energ...

WASHINGTON--(BUSINESS WIRE)--Westinghouse Electric Company e MVM Group hanno stipulato un contratto volto a garantire la diversificazione dell’approvvigionamento di combustibile in Ungheria. Questa partnership assicura alla centrale nucleare di Paks una fornitura affidabile di combustibile VVER prodotto da Westinghouse in Europa. Le consegne di ricariche del combustibile VVER-440 Westinghouse inizieranno nel 2028, subordinatamente al completamento delle procedure di autorizzazione. “Il nostro a...

WASHINGTON--(BUSINESS WIRE)--Westinghouse Electric Company et MVM Group ont signé un contrat visant à garantir la diversification de l’approvisionnement en combustible de la Hongrie. Ce partenariat permettra à la centrale nucléaire de Paks de bénéficier d’un approvisionnement fiable en combustible pour réacteur VVER de Westinghouse, produit en Europe. Les premières livraisons de combustible pour réacteur VVER-440 sont prévues pour 2028, sous réserve de l’obtention des autorisations nécessaires....

WASHINGTON--(BUSINESS WIRE)--Westinghouse Electric Company y MVM Group han firmado un acuerdo para garantizar la diversificación del suministro de combustible en Hungría. Esta colaboración garantiza a la central nuclear de Paks un suministro estable de combustible VVER de Westinghouse, fabricado en Europa. Las entregas de recargas de combustible VVER-440 de Westinghouse comenzarán en 2028, siempre y cuando se obtengan las licencias necesarias. «Nuestro acuerdo con Westinghouse es una clara resp...

WASHINGTON--(BUSINESS WIRE)--Westinghouse Electric Company und die MVM Group haben einen Vertrag zur Diversifizierung des Energieangebots in Ungarn unterzeichnet. Dank dieser Partnerschaft wird das Atomkraftwerk Paks Nuclear Power Plant (NPP) zuverlässig mit Treibstoff von Westinghouse VVER versorgt, der in Europa hergestellt wurde. Die Lieferungen zur Wiederauffüllung von Westinghouse VVER-440 beginnen aufgrund von Lizensierungsangelegenheiten 2028. „Unser Vertrag mit Westinghouse ist eine Rea...

LOS ANGELES--(BUSINESS WIRE)--In the shadow of the Hollywood Bowl, hotel workers at the Hilton Garden Inn hotel in Hollywood started a picket line at 6 AM local time today. The 160-room hotel, owned by RLJ Lodging Trust and operated by Aimbridge Hospitality, expected high occupancy this weekend for one of the last Hollywood Bowl concerts of the year. In Philadelphia, workers at the Wyndham Historic District hotel—also owned by RLJ Lodging Trust and operated by Aimbridge—walked off the job earli...

NEW YORK--(BUSINESS WIRE)--ByHeart, a next-generation baby nutrition company, announced today that, out of an abundance of caution, it has chosen to voluntarily recall two batches of ByHeart Whole Nutrition Infant Formula following notification from the U.S. Food and Drug Administration (FDA) of a broader ongoing investigation into a recent outbreak of infant botulism. Infant botulism is a rare but potentially fatal illness that presents a serious threat to the health of infants which occurs wh...

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced updated data for povetacicept (pove) in IgA nephropathy (IgAN) and primary membranous nephropathy (pMN) from the ongoing RUBY-3 trial at the American Society of Nephrology (ASN) Kidney Week 2025 in Houston, Texas. Pove is an investigational recombinant fusion protein therapeutic and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines. Pove is the on...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced results from new post hoc analyses of the HELIOS-B Phase 3 study of AMVUTTRA® (vutrisiran), an RNAi therapeutic approved for the treatment of the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) and the polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR-PN) in adults. Data from cardiovascular magnetic re...